Skip to content
OpenCapital
Get started

Absci Corporation ABSI Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

Precigen logo
PrecigenPGEN
——
Guardant Health logo
Guardant HealthGH
——
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
——

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0×0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Absci Corporation (ABSI) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $3.19 in Q1 2026.
How has Absci Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
Absci Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price decreased by 5.9% year-over-year, from $3.39 to $3.19.
What is the long-term trend for Absci Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 5 years (2020 to 2025), Absci Corporation's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a 24.3% compound annual growth rate (CAGR), from $1.1 to $3.27.